Priya Nair reads drug labels the way other people read contracts: slowly, twice, and with real attention to the footnotes. As a clinical pharmacologist on a hospital formulary committee, she has spent years deciding which warnings are theoretical and which ones put people in hospital beds, and that judgement is what she brings to the reader questions here.
Her favourite questions are the unglamorous ones: why gabapentin has to be tapered rather than stopped, why steroids are so useful and so easy to misuse, why metformin is started low and slow, and why isotretinoin demands strict pregnancy prevention. She answers with mechanisms first, because a reader who understands the why keeps themselves safer than one who just memorises a rule.
On gabapentin she explains off-label neuropathic pain use, sedation at higher doses, and the renal-dosing ladder. On prednisone she contrasts short bursts for flares with the hazards of long courses — glucose, bone, mood, infection — and why taper schedules exist. On metformin she walks through GI adaptation, B12 monitoring, and when eGFR thresholds change prescribing.
Isotretinoin threads get her strictest voice: iPLEDGE is not bureaucracy for its own sake, cumulative dose targets matter for relapse, and teratogenicity is not negotiable. For fluoxetine she covers the four-to-six-week wait, CYP2D6 interactions that surprise prescribers, and why stopping abruptly is less risky than with shorter half-life SSRIs but still not ideal.
She completed her PharmD at UNC Eshelman and a clinical pharmacology fellowship at Vanderbilt before joining a tertiary hospital formulary committee. Her day job is reconciling seventeen simultaneous medication lists — the same polypharmacy puzzles that show up in ledger threads about gabapentin sedation or metformin eGFR cut-offs.
She cites MedlinePlus, FDA medication guides, and published meta-analyses when a reader asks for sources beyond the ledger. She covers the metabolic, pain, skin and psych corner of the site. Pharmacology on a website is population-level knowledge, and readers are individuals — her replies end with a pointer to a prescriber whenever the honest answer depends on labs, doses, or a medication list she cannot see.
She teaches a monthly polypharmacy clinic for internal-medicine residents and uses anonymised ledger threads as case prompts — the same gabapentin taper or steroid-bridge questions readers post often appear on her teaching slides the following week.
When a thread touches pregnancy, renal dosing, or suicidality in young adults, she ends with an explicit hand-off to the reader's prescriber rather than a dose number she cannot verify remotely.
She maintains a personal checklist for ledger updates: label changes, boxed warnings, and major meta-analyses that shift standard practice — metformin eGFR thresholds, isotretinoin iPLEDGE revisions, and SSRI suicidality monitoring are reviewed on that schedule.